194 related articles for article (PubMed ID: 28677246)
21. How to Capture the Bleeding Phenotype in FXI-Deficient Patients.
Bertaggia Calderara D; Zermatten MG; Aliotta A; Alberio L
Hamostaseologie; 2020 Nov; 40(4):491-499. PubMed ID: 33003209
[TBL] [Abstract][Full Text] [Related]
22. Thrombin generation in patients with factor XI deficiency and clinical bleeding risk.
Rugeri L; Quélin F; Chatard B; De Mazancourt P; Negrier C; Dargaud Y
Haemophilia; 2010 Sep; 16(5):771-7. PubMed ID: 20398070
[TBL] [Abstract][Full Text] [Related]
23. A non-circulating pool of factor XI associated with glycosaminoglycans in mice.
Mohammed BM; Cheng Q; Matafonov A; Verhamme IM; Emsley J; McCrae KR; McCarty OJT; Gruber A; Gailani D
J Thromb Haemost; 2019 Sep; 17(9):1449-1460. PubMed ID: 31125187
[TBL] [Abstract][Full Text] [Related]
24. Why factor XI deficiency is a clinical concern.
Wheeler AP; Gailani D
Expert Rev Hematol; 2016 Jul; 9(7):629-37. PubMed ID: 27216469
[TBL] [Abstract][Full Text] [Related]
25. Effects of factor IX or factor XI deficiency on ferric chloride-induced carotid artery occlusion in mice.
Wang X; Cheng Q; Xu L; Feuerstein GZ; Hsu MY; Smith PL; Seiffert DA; Schumacher WA; Ogletree ML; Gailani D
J Thromb Haemost; 2005 Apr; 3(4):695-702. PubMed ID: 15733058
[TBL] [Abstract][Full Text] [Related]
26. Nonsense mutation in exon V of the factor XI gene does not abolish platelet factor XI expression.
Shirk RA; Konkle BA; Walsh PN
Br J Haematol; 2000 Oct; 111(1):91-5. PubMed ID: 11091186
[TBL] [Abstract][Full Text] [Related]
27. Factor XI deficiency in Iranians: its clinical manifestations in comparison with those of classic hemophilia.
Peyvandi F; Lak M; Mannucci PM
Haematologica; 2002 May; 87(5):512-4. PubMed ID: 12010665
[TBL] [Abstract][Full Text] [Related]
28. In vitro comparison of the effect of two factor XI (FXI) concentrates on thrombin generation in major FXI deficiency.
Pike GN; Cumming AM; Hay CR; Sempasa B; Sutherland M; Thachil J; Burthem J; Bolton-Maggs PH
Haemophilia; 2016 May; 22(3):403-10. PubMed ID: 26558335
[TBL] [Abstract][Full Text] [Related]
29. Sample conditions determine the ability of thrombin generation parameters to identify bleeding phenotype in FXI deficiency.
Pike GN; Cumming AM; Hay CR; Bolton-Maggs PH; Burthem J
Blood; 2015 Jul; 126(3):397-405. PubMed ID: 25911238
[TBL] [Abstract][Full Text] [Related]
30. A novel factor XI missense mutation (Val371Ile) in the activation loop is responsible for a case of mild type II factor XI deficiency.
Bozzao C; Rimoldi V; Asselta R; Landau M; Ghiotto R; Tenchini ML; De Cristofaro R; Castaman G; Duga S
FEBS J; 2007 Dec; 274(23):6128-38. PubMed ID: 17971173
[TBL] [Abstract][Full Text] [Related]
31. Factor XI Deficiency.
Duga S; Salomon O
Semin Thromb Hemost; 2009 Jun; 35(4):416-25. PubMed ID: 19598070
[TBL] [Abstract][Full Text] [Related]
32. Clinical manifestations and mutation spectrum of 57 subjects with congenital factor XI deficiency in China.
Shao Y; Cao Y; Lu Y; Dai J; Ding Q; Wang X; Xi X; Wang H
Blood Cells Mol Dis; 2016 May; 58():29-34. PubMed ID: 27067486
[TBL] [Abstract][Full Text] [Related]
33. [Factor XI deficiency: do patients with hemorrhagic diathesis also have hemostasis defects?].
Peter MK; Meili EO; von Felten A
Schweiz Med Wochenschr; 1996 Jun; 126(23):999-1005. PubMed ID: 8701241
[TBL] [Abstract][Full Text] [Related]
34. Molecular characterization of FXI deficiency.
Berber E
Clin Appl Thromb Hemost; 2011 Feb; 17(1):27-32. PubMed ID: 20308231
[TBL] [Abstract][Full Text] [Related]
35. Bleeding phenotype and correlation with factor XI (FXI) activity in congenital FXI deficiency: results of a retrospective study from a single centre.
Santoro C; Di Mauro R; Baldacci E; De Angelis F; Abbruzzese R; Barone F; Bochicchio RA; Ferrara G; Guarini A; Foà R; Mazzucconi MG
Haemophilia; 2015 Jul; 21(4):496-501. PubMed ID: 25623511
[TBL] [Abstract][Full Text] [Related]
36. Abrogating fibrinolysis does not improve bleeding or rFVIIa/rFVIII treatment in a non-mucosal venous injury model in haemophilic rodents.
Stagaard R; Flick MJ; Bojko B; Goryński K; Goryńska PZ; Ley CD; Olsen LH; Knudsen T
J Thromb Haemost; 2018 Jul; 16(7):1369-1382. PubMed ID: 29758126
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic plasma exchange for perioperative management of patients with congenital factor XI deficiency.
Alsammak MS; Ashrani AA; Winters JL; Pruthi RK
J Clin Apher; 2017 Dec; 32(6):429-436. PubMed ID: 28295573
[TBL] [Abstract][Full Text] [Related]
38. The evolution of factor XI and the kallikrein-kinin system.
Ponczek MB; Shamanaev A; LaPlace A; Dickeson SK; Srivastava P; Sun MF; Gruber A; Kastrup C; Emsley J; Gailani D
Blood Adv; 2020 Dec; 4(24):6135-6147. PubMed ID: 33351111
[TBL] [Abstract][Full Text] [Related]
39. Factor XI and coagulation. Factor XI inhibitors - antithrombotic perspectives.
Vlădăreanu AM; Roşca A
Rom J Intern Med; 2024 Jun; 62(2):91-100. PubMed ID: 38153875
[TBL] [Abstract][Full Text] [Related]
40. Antithrombotic effect of antisense factor XI oligonucleotide treatment in primates.
Crosby JR; Marzec U; Revenko AS; Zhao C; Gao D; Matafonov A; Gailani D; MacLeod AR; Tucker EI; Gruber A; Hanson SR; Monia BP
Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1670-8. PubMed ID: 23559626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
